The many faces of the Small Ubiquitin like Modifier
Current: Subhradip Das, Amrita Roy
Past: Amar Soory, Bhagyashree Kaduskar, Mithila Handu, Prajna Nayak, Sushmitha Hegde
The post-translational modifier, SUMO, can modulate the structure, folding, stability, dynamics, function or location of a target protein post conjugation. Many proteins that are SUMO targets play important roles in important physiological processes. We have chosen immune signaling and early embryonic development as two stages to understand SUMO's ability to modulate biological phenomenon. In the Immune system, using quantitative proteomics, we have defined a set of proteins that change their SUMOylation status after mock infection (Handu et. al., 2015). Many of these SUMO-conjugated proteins have important roles in immune signaling and we are currently working towards defining the effect of SUMO conjugation on each of the central immune signaling pathways, Toll/NfkB, IMD/NFkB and the JNK signal transduction cascades. Proteomics has also been used to define a set of proteins SUMO conjugated in the early 0-3 embryo by the Courey laboratory (Nie et. al., 2009), where the primary axis (Anterior/Posterior; Dorsal/Ventral; Terminal), of the animal are being established. We are using CRISPR/Cas9 based genome editing to generate SUMO-conjugation resistant proteins and studying their effect in the organism.